{"entity":{"id":"nct06193902","kind":"trial","name":"LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours.","aka":[],"tldr":"A phase 1/2 trial of LEU011 in advanced solid tumours, run by Leucid Bio, now recruiting.","summary":"LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours. is a phase 1/2 interventional study registered as NCT06193902 by Leucid Bio, with 17 participants planned, started 2023-11-13 and due to reach its primary completion in 2029-05. Interventions recorded: LEU011.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06193902","url":"https://clinicaltrials.gov/study/NCT06193902"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06193902","phase":"1/2","setting":"A Phase I/IIa Open-label Dose Escalation Trial Evaluating the Safety and Preliminary Efficacy of LEU011 in Subjects With Relapsed/Refractory Solid Tumours","sponsor":"Leucid Bio","enrolled":17,"outcomes":[]},"route":"/trials/nct06193902/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}